IQVIA HOLDINGS INC. Reclassification from AOCI, Current Period, before Tax, Attributable to Parent
IQVIA HOLDINGS INC. (IQV) reported Reclassification from AOCI, Current Period, before Tax, Attributable to Parent of -$7.00 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-10-22.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent · last filed 2021-10-22
- IQVIA HOLDINGS INC. reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2021-09-30 was -$3.00M.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2021-06-30 was -$3.00M, a 125.00% decline year-over-year.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2021-03-31 was -$1.00M.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, before tax, attributable to parent for the quarter ending 2020-09-30 was -$2.00M.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, before tax, attributable to parent for fiscal 2016 was -$22.00M.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, before tax, attributable to parent for fiscal 2015 was -$13.00M.
- IQVIA HOLDINGS INC. reclassification from aoci, current period, before tax, attributable to parent for fiscal 2014 was -$2.00M.
| Period end | Reclassification from AOCI, Current Period, before Tax, Attributable to Parent 3 month | Reclassification from AOCI, Current Period, before Tax, Attributable to Parent 6 month | Reclassification from AOCI, Current Period, before Tax, Attributable to Parent 9 month | Reclassification from AOCI, Current Period, before Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | -$6.00M derived: sum of 2 quarters · filed 2021-10-22 | -$7.00M 10-Q · filed 2021-10-22 | |
| 2021-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$4.00M 10-Q · filed 2021-07-28 | ||
| 2021-03-31 | -$1.00M 10-Q · filed 2021-04-23 | |||
| 2020-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | $10.00M derived: sum of 2 quarters · filed 2020-10-22 | -$6.00M 10-Q · filed 2020-10-22 | |
| 2020-06-30 | $12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | -$4.00M 10-Q · filed 2020-07-23 | ||
| 2020-03-31 | -$16.00M 10-Q · filed 2020-04-30 | |||
| 2016-12-31 | -$22.00M 10-K · filed 2017-02-16 | |||
| 2015-12-31 | -$13.00M 10-K · filed 2017-02-16 | |||
| 2014-12-31 | -$2.00M 10-K · filed 2017-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |